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We asked 12 leaders in the stem cell and aging fields to share their personal perspectives on the future of the






for the Biology of AgingThe germline is an immortal lineage in that
germline stemcellsproducegametes,which
generate new embryos through fertilization.
Early in development, a new germline is
specified, giving rise to stem cells and gam-
etes, which begin the process anew. These
germline cycles continue for countless gen-
erations in propagating the species, seem-
ingly without the adverse consequences of
limitless proliferation. In contrast, the soma
executes mundane tasks enabling the or-
ganism to eat, metabolize, strategize, and
maneuver through its environment. Somatic
tissuesand thestemcells thatmaintain them
evolved to execute these tasks efficiently,
but only through the reproductive life of the
animal. Thus, the pronounced aging of the
soma may reflect the absence of mecha-
nismsselected for in thegermline to facilitate
endless renewalwithout itsattendantconse-
quences. Factors that affect genome integ-
rity, such as DNA damage, mutations, and
epigenetic alterations are prime candidates
to explain potential differences in germline
and somatic aging. Differences in relative
mutation rates are unclear, but greater fidel-
ity of replication or repair may exist in the
germline. It is well recognized that telomeres
are efficiently maintained in the humanmale
germline during aging, in contrast to the
marked telomere shortening in somatic tis-
sues. The basis for the difference is un-
known, but may provide important clues
regarding enhanced genome maintenance
mechanisms in the germline compared
with the soma.578 Cell Stem Cell 16, June 4, 2015 ª2015 ERejuvenating Musclelsevier Inc.Muscle stem cells (MuSCs) are responsible
for the maintenance and regeneration of
skeletal muscle mass and are crucial to
mobility and quality of life. During aging,
the regenerative capacity of MuSCs dimin-
ishes and is accompanied by cumulative
deleterious systemic, cellular, and meta-
bolic factors. We now know that with
advanced age the proportion of MuSCs
that are capable of regeneration progres-
sively declines due to cell-intrinsic
changes. Deficits include aberrantly active
cell signaling pathways, increased expres-
sion of senescence markers, and a reduc-
tion in stem cell proliferative capacity. Es-
tablishing the tipping point for the array of
cell-intrinsic defects affords a new thera-
peutic opportunity and requires a new tool-
kit. Single-cell analyses will be essential for
identifying MuSCs with enhanced regener-
ative properties. Insights into young and
aged MuSCs will arise from time-lapse an-
alyses of genealogic lineage trees that
track cellular behavior in response to
biochemical and biophysical cues within
deconstructed niches. Single-cell mass cy-
tometry and transcriptome analyses will
highlight the signaling pathways that go
awry and the cell surface molecules that
can be used to isolate the most functional
subset in the aged MuSC population. This
knowledge will guide the quest to identify
therapeutic agents that target and expand
the residual robustly regenerative MuSCs
in aged muscle tissues, thus enabling tis-
sue rejuvenation critical to muscle repair
in the elderly. (Photograph by Amparo
Garrido.)The Epigenetics of Self-RenewalSelf-renewal defines stem cells, and if stem
cells perfected self-renewal, they would
not age. However, most stem cells,
including those in the hematopoietic sys-
tem, lose function over time. Hematopoiet-
ic stem cell (HSC) decline likely contributes
to age-related hematological disorders,
which are rising as the world population
ages. So how is self-renewal regulated at
the molecular level, and how is this
compromised during the aging process?
Is stem cell decline caused by an accumu-
lation of random genetic aberrations or by
an erosion of epigenetic modifications?
The answer is not only of scientific interest
but is also relevant for emerging efforts
aimed at reversing the aging process. If
stem cell aging results from accumulating
DNA damage, reversion of stem cell aging
seems difficult. In contrast, if stem cell ag-
ing occurs as a consequence of altered
epigenetic modifications, reversibility may
be achievable. Molecules that affect the
epigenetic machinery exist with more on
the way. Reversing stem cell aging will
also depend on whether aging is a cell-
intrinsic or cell-extrinsic process. Most
data suggest that HSC aging is mostly
caused by cell-intrinsic causes, but the
final verdict is still out. Indeed, it may be
most likely that both pathways are
involved. The next decade will reveal, at
the single-cell level, how HSCs distribute
their epigenetic patterns to their daughters,
which of these modifications are crucial for
stem cell function, and how they are per-
turbed during aging.
Cell Stem Cell




Baylor College of Medicine
Leanne Jones
University of California, Los
Angeles‘‘Epigenetic drifts’’ are one of the hallmarks
of stem cell aging and are an exciting novel
area of research. However, how such drifts
causally contribute to stem cell aging has
remained a puzzle. Novel observations
suggest that epigenetic marks and the ma-
chineries of epigenetic maintenance also
serve a structural function for the genome
itself—that is, they regulate 3D interactions
between modules that may be separated
by considerable linear distance as well as
contribute to the overall 3D layout of the
genome. An epigenetic understanding of
stem cell aging thus moves from linear
gene regulation into the 3D world. Recent
breakthroughs—for example, the applica-
tion of the C technologies to single cells,
advances in microscopy-based tech-
niques, and improvements in computa-
tional modeling—will continue to close
our knowledge gap with respect to this
fascinating structural function of epige-
netics in stem cells. The emerging picture
suggests that the spatial organization of
the epigenome as a self-organizing and
self-perpetuating system uses these
epigenetic 3D dynamics to regulate
genome function in response to many
cues and to propagate cell-fate memory
over chronological time and divisions.
Studying the 3D perspective of the epige-
nome with respect to stem cell aging has
just begun, and it will certainly unravel
novel unexpected mechanisms that might
serve as pharmacological targets to
improve stem cell and tissue aging in the
future.Aging HSCs and Clonal CollapseTurning 50 this year got me thinking about
the health of my stem cells and how they
will care for me over the next half century.
(The melanocyte stem cells on my head
having given out years ago, I wish I could
peek in my bone marrow.) When young,
we are estimated to have about 10,000 he-
matopoietic stem cells of which 1,000
actively contribute to the blood. Recent
data from multiple groups, including the
Ley, Ebert, McCarroll, and Vassiliou labs,
suggest that number drops precipitously
after the age of 50, such that around 10%
of 70-year-olds have a single clone
comprising a large fraction of their blood.
This finding is not a fluke: together these
studies surveyedmore than 70,000 individ-
uals across all ages. What drives this clonal
hematopoiesis? What are the long-term
health implications? What is my own clonal
diversity (and should I care)? Mutations in
about 20 genes, including DNMT3A,
TET2, and TP53, are recurrently associated
with clonal collapse, possibly because they
confer stem cells with a competitive self-
renewal advantage (as my lab suggested
for Dnmt3a and Tp53 in mice). Individuals
with clonal hematopoiesis have higher all-
cause mortality, suggesting an impact on
multiple aspects of health. I believe these
studies will cause a sea change in our
view of healthy aging, and over time they
may lead to clonal diversity monitoring
and possibly interventions to shift the
advantage away from troublesome clones.
At the very least, these stem cells will keep
me busy for the next few decades.Cell Stem CeCountering Stem Cell Agingll 16, June 4, 2015 ª2015 Elsevier Inc. 579The proper integration of intrinsic factors
and extrinsic signals is essential for precise
regulation of stem cell behavior and tissue
homeostasis. Therefore, it is predicted
that defects at all levels (intrinsic, local,
and systemic) will contribute to decreased
stem cell functionality over time. Significant
insights have been gained in characterizing
the causes of decreased stem cell function
in a range of tissues, but strategies to
reverse these changes that will be clinically
feasible have yet to be established. With
the ultimate goal of restoring stem cell
function to sustain healthy tissues, a major
challenge will be determining whether tar-
geting one level of stem cell regulation
(e.g., reversing extrinsic defects) will be
sufficient to alter stem cell aging pheno-
types. Although promising results have
been demonstrated for some tissues, for
others it may be necessary to develop stra-
tegies to target both extrinsic and intrinsic
mechanisms that will work synergistically
to improve stem cell function in an aged in-
dividual. Another fundamental question
concerns the timing for implementation of
such anti-aging strategies—ideally before
diseased states are recognized. As we all
age at different rates, having a mechanism
to predict when an individual may be on the
cusp of needing treatment will be benefi-
cial. Therefore, defining a set of genetic
and/or biochemical markers to determine
an individual’s rate of aging early in life
also presents an exciting challenge for the
future.
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580 Cell Stem Cell 16, June 4, 2015 ª201Our understanding of the impact of aging
on stem cells and on the susceptibility of
stem cells to malignant transformation is
rapidly evolving. We have long known that
the regenerative capacity of different so-
matic tissues changes with age and time,
and that the risk of developing cancer is
highly dependent on age. However, our un-
derstanding of the basis for these observa-
tions remains incomplete. The recent
observation that some elderly subjects
have mutant stem cells that undergo clonal
expansion has opened our eyes to the idea
that stem cells can undergo clonal evolu-
tion, even in the absence of overt malignant
transformation. How do these mutations,
most commonly found in epigenetic regu-
lators, increase self-renewal and stem cell
fitness without invariably leading to malig-
nancy? Do these mutations induce a spe-
cific epigenetic program, or do they allow
for epigenetic instability that then serves
as a platform for a specific transcriptional
program to evolve over time? Can this pro-
cess be reversed once it has begun? We
and others will spend considerable efforts
to understand how clonal evolution in aging
stem cells alters self-renewal and sets the
stage for malignancy. However, there are
many other questions that need to be ad-
dressed in our field, including whether the
aging process, independent of clonal evo-
lution, can alter the stem cell epigenome
and influence the proclivity for transforma-
tion. There has never been a better time to
ask and investigate these questions.5 EQuiescence Prescribes Stemnesslsevier Inc.Adult stem cells sustain tissue regenera-
tion, and their dysfunction with age causes
degenerative disease. Over the past
decade, heterochronic studies in skeletal
muscle have revolutionized the view of
the dynamic interactions of muscle stem
cells (satellite cells) and the external envi-
ronment by showing that exposure to a
youthful environment can reestablish the
regenerative capacity of old muscle, sug-
gesting that stem cell alterations may be
tractable. Recent observations have both
clarified and complicated this view by
showing that cell-intrinsic alterations that
cannot be reversed by a youthful environ-
ment also contribute to satellite cell decline
with aging, particularly at geriatric age. One
unexpected finding is that these irrevers-
ible cell-intrinsic changes especially affect
quiescence, the normal dormancy state
that maintains satellite cell stemness, pro-
voking a senescence switch that impairs
regenerative functions. Understanding the
mechanisms underlying loss of quiescence
and acquisition of senescence in geriatric
stem cells may help design strategies to
delay age-associated tissue decline. I pro-
pose that the bona fide functionally revers-
ible quiescent state, rather than a collec-
tion of phenotypic markers, is the key for
defining stemness in satellite cells. This
revised view presents new venues for
discerning the function of muscle stem
cells in homeostasis, aging, and pathology
and for stimulating endogenous stem cells
or transplanting exogenous stem cells in
therapeutics.Stem Cells Age. or Do They?‘‘Yet who would have thought the
oldman to have had somuch blood
in him.’’ —Lady Macbeth, Hamlet
Age-dependent decline in stem cell fitness
may underlie impaired tissue maintenance
and regeneration as well as degenerative
diseases and cancer. Stem cells are best
studied in their natural environment in vivo;
yet, such experiments remain challenging.
In the field of hematopoietic stem cells
(HSCs), transplantation has been the main-
stay of research and clinical applications.
Recent experiments in mice uncovered
fundamental differences in HSC function
when comparing unperturbed in situ
HSCs with post-transplantation hemato-
poiesis. A hallmark of aging HSCs, as
deduced from transplantation, was prefer-
ential production of myeloid over lymphoid
lineage cells. However, modern fate map-
ping experiments found a drastic ‘‘myeloid
bias’’ already in young HSCs that only
marginally increased with age. Measure-
ments combined with mathematical
modeling revealed normal hematopoietic
flow emerging from aged HSCs, leading
us to speculate that HSCs could theoreti-
cally outlive the mouse itself. This counter-
intuitive view fits the old man’s enormous
bloodstain that shook Lady Macbeth. Had
she been able to discriminate leukocytes,
she would have found healthy granulocytes
and monocytes, probably also some naive
T and B lymphocytes, born recently from
‘‘old’’ HSCs. Hence, we need to clarify
whether ‘‘stem cell aging’’ is the rule or
the exception, and to what extent it con-
tributes to lifespan limitations and tissue
failing.
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Amy Wagers
Harvard UniversityThe surprising observation, made 30 years
ago in C. elegans, that inactivation of even
a single gene can be sufficient to slow the
aging process and significantly extend life-
span marked a revolution in aging research
because it demonstrated that aging can
and should be viewed as a biochemically
controlled process suitable for molecular
dissection, rather than a simple process
of ‘‘wear and tear.’’ A similar revolution
has occurred more recently, with the
growing appreciation that not only can the
effects of aging be slowed—they may be
reversed. Indeed, studies in mice have
now demonstrated that certain interven-
tions, including telomerase reactivation,
senescent cell ablation, alteration of neuro-
endocrine signaling, and exposure to age-
variant systemic factors can restore
‘‘youthful’’ function in many, distinct aged
tissues. The cellular and molecular media-
tors of these effects are beginning to be un-
covered, and they are thus far consistent
with the existence of common networks
regulating age-associated decline and
‘‘rejuvenation’’ across organ systems.
These findings present exciting possibil-
ities for regenerative medicine and also
raise the fascinating question: what is reju-
venation in molecular terms? How is
cellular function remodeled by these inter-
ventions, and do rejuvenated cells truly re-
turn to a durable youthful state? Answering
this question will resolve essential issues in
aging physiology and enable new treat-
ments that can improve human health
throughout the lifespan.DDR in Stem Cells and ProgenyCell StemThe maintenance of stem cell functionality
is essential for tissue homeostasis, a failure
of which leads to organ impairment and
premature aging. The aging process oc-
curs in two types of cells: stem cells and
postmitotic terminally differentiated so-
matic cells. The DNA damage response
(DDR), including DNA repair, cell-cycle
checkpoints, and apoptosis, safeguards
the high fidelity of the genetic information
amplified in stem cells and dictates cell sta-
tus, leading to either (1) temporal or perma-
nent arrest of proliferation or (2) apoptosis,
both of which ultimately impact tissue ho-
meostasis. Mutations in the DDR cascade
cause developmental disorders as well as
progeroid syndromes, likely due to the
DNA repair defects affecting stem cells
during development. Emerging evidence
also suggests the commonality of DDRdef-
icits in the decline of adult stem cells and
organs during aging.
The key questions facing the field are
whether or how the DDR mechanism oper-
ates in postmitotic somatic cells and how
the genome fitness of stem cells influences
the functional competence of their postmi-
totic (somatic) progenies in adult life. Given
that neural impairment is a major aging-
associated public health burden, investi-
gating the role of the DDR molecules in
the transition of neural stem cells to post-
mitotic neurons should unravel ‘‘novel’’
functions of the DDR machineries in neural
regeneration and degeneration, which may
also offer clues on how DDR ultimately
prevents tissue impairment and premature
aging.CeImmortality of Germ Cellsll 16, June 4, 2015 ª2015 Elsevier Inc. 581Although we consider aging as an inevi-
table aspect of an organism’s life, it is a
strange phenomenon in the face of the
seemingly immortal nature of germ cells.
This paradox represents a fundamental
mystery in biology: if germ cells can rejuve-
nate from one generation to the next, why
don’t all other somatic cells do so to create
an immortal individual that can keep repro-
ducing forever? In other words, if there is a
fundamental barrier to achieving immor-
tality in somatic cells, then why can germ
cells overcome it?
Interestingly, germ cell production clearly
declines with age, implying that there is
no magic potion to maintain cells forever
(and I do not think that such a decline is
purely caused by a decline in gonadal so-
matic cells). This makes it even more
intriguing to ask, ‘‘What is really happening
in gametogenesis that makes germ cells
look as if they are rejuvenated?’’ The only
logical answer seems to be that there is a
huge sacrifice/cost in rejuvenating germ
cells that is not affordable for somatic cells
or is incompatible with their function.
Tackling these questions is not just within
the scope of germ cell biology or aging
biology: it is a question for all biology. Un-
derstanding how germ cells achieve
immortality will provide fundamental
insight into why we age as well. I would
be thrilled to tackle (even bits and pieces
of) these questions and/or witness the
answer or answers to come into our view.
Can I predict when it might happen? No—
science is never predictable. (Photo: Mich-
igan Photo Service.)
